| 臺大學術典藏 |
2021-09-04T05:16:31Z |
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T05:16:31Z |
HIGHLIGHTS
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:30Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:30Z |
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
|
Yeo Y.H.; Tseng T.-C.; Hosaka T.; Cunningham C.; Fung J.Y.Y.; Ho H.J.; Kwak M.-S.; Trinh H.N.; Ungtrakul T.; Yu M.-L.; Kobayashi M.; Le A.K.; Henry L.; Li J.; Zhang J.; Sriprayoon T.; Jeong D.; Tanwandee T.; Gane E.; Cheung R.C.; Wu C.-Y.; Lok A.S.; Lee H.-S.; Suzuki F.; Yuen M.-F.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H. |
| 臺大學術典藏 |
2021-09-04T05:16:30Z |
Progress towards elimination goals for viral hepatitis
|
Cox A.L.; El-Sayed M.H.; JIA-HORNG KAO; Lazarus J.V.; Lemoine M.; Lok A.S.; Zoulim F. |
| 臺大學術典藏 |
2021-09-04T05:16:29Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:29Z |
Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
|
Lin C.-L.; Tseng K.-C.; Chen K.-Y.; Liao L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:29Z |
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan
|
Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J. |
| 臺大學術典藏 |
2021-09-04T05:16:28Z |
Relationship between serum gamma-glutamyl transferase level and colorectal adenoma
|
Hong T.-C.; Yang H.-C.; Chen C.-L.; JIA-HORNG KAO; Liu C.-J.; Chen M.-J.; Wang H.-Y.; Kuo Y.-C.; Yu L.-Y.; Hu K.-C. |
| 臺大學術典藏 |
2021-09-04T05:16:28Z |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group |
| 臺大學術典藏 |
2021-09-04T05:16:27Z |
Reply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCT
|
Huang C.-F.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:27Z |
The association of vitamin D with hepatitis B virus replication: Bystander rather than offender
|
Wang C.-C.; Tzeng I.-S.; Su W.-C.; Li C.-H.; Lin H.H.; Yang C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:27Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:26Z |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2021-09-04T05:16:26Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:26Z |
East Asia expert opinion on treatment initiation for chronic hepatitis B
|
JIA-HORNG KAO; Hu T.-H.; Jia J.; Kurosaki M.; Lim Y.-S.; Lin H.-C.; Sinn D.H.; Tanaka Y.; Wai-Sun Wong V.; Yuen M.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:25Z |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
|
Eslam M.; Sarin S.K.; Wong V.W.-S.; Fan J.-G.; Kawaguchi T.; Ahn S.H.; Zheng M.-H.; Shiha G.; Yilmaz Y.; Gani R.; Alam S.; Dan Y.Y.; JIA-HORNG KAO; Hamid S.; Cua I.H.; Chan W.-K.; Payawal D.; Tan S.-S.; Tanwandee T.; Adams L.A.; Kumar M.; Omata M.; George J. |
| 臺大學術典藏 |
2021-09-04T05:16:25Z |
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
|
Liu C.-H.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:25Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:24Z |
Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: A practice implication
|
Ogawa E.; Toyoda H.; Iio E.; Jun D.W.; Huang C.-F.; Enomoto M.; Hsu Y.-C.; Haga H.; Iwane S.; Wong G.; Lee D.H.; Tada T.; Liu C.-H.; Chuang W.-L.; Hayashi J.; Cheung R.; Yasuda S.; Tseng C.-H.; Takahashi H.; Tran S.; Yeo Y.H.; Henry L.; Barnett S.D.; Nomura H.; Nakamuta M.; Dai C.-Y.; Huang J.-F.; Yang H.-I.; Lee M.-H.; Jun M.J.; JIA-HORNG KAO; Eguchi Y.; Ueno Y.; Tamori A.; Furusyo N.; Yu M.-L.; Tanaka Y.; Nguyen M.H.; Ahn S.B.; Azuma K.; Dohmen K.; Jeong J.Y.; Jung J.H.; Kajiwara E.; Kato M.; Kawano A.; Koyanagi T.; Ooho A.; Park S.H.; Satoh T.; Shimoda S.; Song D.S.; Takahashi K.; Yeh M.-L.; Yoon E.L.; Real-World Evidence from the Asia Liver Consortium Investigators |
| 臺大學術典藏 |
2021-09-04T05:16:24Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:24Z |
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection—Authors' reply
|
Wai-Sun Wong V.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:23Z |
Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling
|
Hsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO; Huang K.-W. |
| 臺大學術典藏 |
2021-09-04T05:16:23Z |
Reply to: “Sofosbuvir and the risk of kidney dysfunction”
|
Liu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:23Z |
Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' reply
|
Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:22Z |
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
|
JIA-HORNG KAO; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:22Z |
Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma
|
Wu C.-H.; Liang P.-C.; Su T.-H.; Lin M.-C.; Chang Y.-H.; Shih T.T.-F.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Response to letter to the editor “Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy”
|
Lin C.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study
|
Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
|
Liu M.; Tseng T.-C.; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H. |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment
|
Tseng T.-C.; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
Response to letter to the editor “The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma”
|
Cheng Y.-M.; Tzeng I.-S.; JIA-HORNG KAO; Wang C.-C. |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
|
Wang C.-C.; Tseng K.-C.; Tzeng I.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
Artificial intelligence in precision medicine in hepatology
|
Su T.-H.; Wu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
|
Huang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
The metabolic profiles and body composition of lean metabolic associated fatty liver disease
|
Cheng Y.-M.; JIA-HORNG KAO; Wang C.-C. |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Reply to “Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia”
|
Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:16Z |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Yu M.-L. |
| 臺大學術典藏 |
2019-10-14T05:52:27Z |
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma
|
Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU |
| 臺大學術典藏 |
2019-10-14T05:52:27Z |
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma
|
Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU |
| 臺大學術典藏 |
2019-09-09T00:55:30Z |
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B
|
Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping |
| 臺大學術典藏 |
2019-09-09T00:55:30Z |
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B
|
Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
